Amoebicidal Effect of Fluconazole and Verapamil Together Against Trophozoites and Cysts of Acanthamoeba castellanii
暂无分享,去创建一个
[1] P. Thulasi,et al. Update on the Management of Acanthamoeba Keratitis , 2022, Current Ophthalmology Reports.
[2] C. Gunduz,et al. The Risk Factors and Clinical Features of Acanthamoeba Keratitis: First Time Detection of Acanthamoeba T5 Genotype from Keratitis Patients in Turkey , 2022, Acta Parasitologica.
[3] K. Megha,et al. Evaluation of in vitro activity of five antimicrobial agents on Acanthamoeba isolates and their toxicity on human corneal epithelium , 2021, Eye.
[4] T. Tia,et al. Analysis of Acanthamoeba genotypes from public freshwater sources in Thailand reveals a new genotype, T23 Acanthamoeba bangkokensis sp. nov. , 2021, Scientific Reports.
[5] A. Huang,et al. Acanthamoeba Keratitis, Pathology, Diagnosis and Treatment , 2021, Pathogens.
[6] S. Bonini,et al. Challenges in Acanthamoeba Keratitis: A Review , 2021, Journal of clinical medicine.
[7] Ana Gomes de Lacerda,et al. Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology , 2020, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[8] A. Baig,et al. Targeting CNS Related Protist Pathogens: Calcium Ion Dependency in the Brain-Eating Amoebae. , 2019, ACS chemical neuroscience.
[9] Zohaib Rana,et al. Evidence of human‐like Ca2+ channels and effects of Ca2+ channel blockers in Acanthamoeba castellanii , 2019, Chemical biology & drug design.
[10] A. Baig. Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications , 2018, Eye.
[11] B. Seitz,et al. Acanthamoeba keratitis – Clinical signs, differential diagnosis and treatment , 2018, Journal of current ophthalmology.
[12] J. Dart,et al. Acanthamoeba keratitis: confirmation of the UK outbreak and a prospective case-control study identifying contributing risk factors , 2018, British Journal of Ophthalmology.
[13] Ayaz Anwar,et al. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole , 2017, Parasitology Research.
[14] M. Karakuş,et al. First time identification of Acanthamoeba genotypes in the cornea samples of wild birds; Is Acanthamoeba keratitis making the predatory birds a target? , 2017, Experimental parasitology.
[15] Y. Hamada,et al. Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates. , 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[16] D. de Freitas,et al. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus. , 2017, Survey of ophthalmology.
[17] Payal Gupta,et al. Antihypertensive, Amlodipine Besilate Inhibits Growth and Biofilm of Human Fungal Pathogen Candida. , 2016, Assay and drug development technologies.
[18] Liuping Zhang,et al. Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans , 2016, PloS one.
[19] J. Lorenzo-Morales,et al. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment , 2015, Parasite.
[20] Qilin Yu,et al. Inhibitory effect of verapamil on Candida albicans hyphal development, adhesion and gastrointestinal colonization. , 2014, FEMS yeast research.
[21] Yu Wang,et al. The Calcium Channel Blocker Verapamil Inhibits Oxidative Stress Response in Candida albicans , 2014, Mycopathologia.
[22] Ziwen Zhao,et al. Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China , 2013, BMC Infectious Diseases.
[23] D. Leonardi,et al. Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents , 2013, BioMed research international.
[24] N. Khan,et al. In Vitro Efficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 Genotype , 2013, Antimicrobial Agents and Chemotherapy.
[25] F. Schuster,et al. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. , 2007, FEMS immunology and medical microbiology.
[26] N. Khan. Acanthamoeba: biology and increasing importance in human health. , 2006, FEMS microbiology reviews.
[27] G. Cabral,et al. Acanthamoeba spp. as Agents of Disease in Humans , 2003, Clinical Microbiology Reviews.
[28] A. Rodrigues,et al. Inhibition of Germ Tube Formation by Candida albicans by Local Anesthetics: An Effect Related to Ionic Channel Blockade , 2000, Current Microbiology.
[29] J. Dart,et al. Risk factors for acanthamoeba keratitis in contact lens users: a case-control study , 1995, BMJ.
[30] S. Kilvington,et al. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. , 1994, Investigative ophthalmology & visual science.
[31] M. Osato,et al. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba. , 1991, Reviews of infectious diseases.
[32] Sonali K Kalra,et al. Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis. , 2019, Experimental parasitology.
[33] J. D. de Jonckheere. Ecology of Acanthamoeba. , 1991, Reviews of infectious diseases.